Asia-pacific Multiplex Assay Market Forecast 2021-2028

Asia-pacific Multiplex Assay Market Forecast 2021-2028


The Asia-Pacific multiplex assay market is predicted to record a CAGR of 9.70% over the projected years of 2021 to 2028. Factors like the growing number of hospitals across emerging economies, technological advancements in the field of healthcare, the augmenting research and development sector, the rising healthcare reforms, and the increasing demand for healthcare infrastructure are expected to fuel the regional market’s growth.


The Asia-Pacific multiplex assay market growth assessment includes the analysis of Vietnam, China, Thailand, Australia & New Zealand, India, South Korea, Indonesia, Japan, and the rest of the Asia-Pacific. As per the statistics issued by GLOBOCAN 2018, 1,157,294 new cancer cases were projected in India, with breast, lip, oral cavity, cervical, and lung cancer as the most prevalent types. In addition, the International Agency for Research on Cancer predicted that this number is expected to increase to 1.55 million by 2030. The increase in the number of overall cases of cancer in India is primarily attributed to major risk factors such as cigarette smoking and the consumption of tobacco.

According to the estimations of the International Agency for Research on Cancer 2018, approximately 277,000 new cases of cancer were recorded in South Korea. The number is anticipated to rise to nearly 368,500 over the upcoming decade. Moreover, the stable growth of multiple assays in the country is predominantly accredited to the mounting demand for quality healthcare as well as the rising need for point-of-care testing (POCT) and molecular testing. Hence, these factors are set to propel the market growth in the Asia-Pacific over the forecasted period.


Some of the leading companies operating in the market are Seegene Inc, F. Hoffmann-La Roche Ltd, Bio-Techne Corporation, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Preference Of Multiplex Assays Over Conventional Assays
3.1.2. Adoption Of Personalized Medicines
3.2. Key Restraints
3.2.1. Unavailability Of Skilled Lab Technicians
3.2.2. Compliance With Strict Environmental Regulation
4. Key Analytics
4.1. Impact Of Covid-19 On Multiplex Assay Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Key Buying Criteria
4.5. Opportunity Matrix
4.6. Vendor Landscape
5. Market By Type
5.1. Protein-based Multiplex Assay
5.2. Nucleic Acid-based Multiplex Assay
5.3. Other Multiplex Assays
6. Market By Product
6.1. Reagents And Consumables
6.2. Instruments And Accessories
6.3. Software And Services
7. Market By Technology
7.1. Multiplex Protein Microarray
7.2. Multiplex Pcr
7.3. Other Technologies
8. Market By Application
8.1. Clinical Diagnostics
8.2. Research And Development
8.3. Companion Diagnostics
9. Market By End-user
9.1. Hospitals
9.2. Clinical Laboratories
9.3. Research Institutes
9.4. Pharmaceutical & Biotechnology Companies
10. Geographical Analysis
10.1. Asia-pacific
10.2. Market Size & Estimates
10.3. Key Growth Enablers
10.4. Key Challenges
10.5. Key Players
10.6. Country Analysis
10.6.1. China
10.6.2. Japan
10.6.3. India
10.6.4. Australia & New Zealand
10.6.5. South Korea
10.6.6. Thailand
10.6.7. Indonesia
10.6.8. Vietnam
10.6.9. Rest Of Asia-pacific
11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Mergers & Acquisitions
11.1.2. Product Launches & Developments
11.1.3. Partnerships & Agreements
11.1.4. Business Expansions, Announcements, And Divestitures
11.2. Company Profiles
11.2.1. Abcam
11.2.2. Agilent Technologies Inc
11.2.3. Becton, Dickinson And Company (Bd)
11.2.4. Bio-rad Laboratories Inc
11.2.5. Bio-techne Corporation
11.2.6. F. Hoffmann-la Roche
11.2.7. Illumina Inc
11.2.8. Luminex Corporation
11.2.9. Merck Millipore
11.2.10. Olink Proteomics Ab
11.2.11. Qiagen Nv
11.2.12. Randox Laboratories Ltd
11.2.13. Seegene Inc
11.2.14. Siemens Healthineers Ag
11.2.15. Thermo Fisher Scientific Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook